Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.52 |
| ▸ | FNTA | P49354 | 3/20 | 0.47 |
| ▸ | FNTB | P49356 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | SNCA | P37840 | 1/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ICMT | O60725 | 1/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14815644 | 1.00 | TRPV1 (0.52) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL15246439 | 1.00 | TRPV1 (0.52) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL21436889 | 0.99 | TRPV1 (0.53) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL27733182 | 0.88 | TRPV1 (0.56) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL15246442 | 0.88 | TRPV1 (0.56) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL23802602 | 0.88 | TRPV1 (0.56) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL8058501 | 0.88 | TRPV1 (0.56) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL8058497 | 0.88 | TRPV1 (0.56) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL5454962 | 0.86 | TRPV1 (0.50) | TRPV1FNTAFNTBMAPTPGR | |
| SCHEMBL3092862 | 0.86 | TRPV1 (0.58) | TRPV1FNTAFNTBALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912654-B2 | Process for stereospecific synthesis of vitamin K2 and its novel intermediates | SYNERGIA LIFE SCIENCES PVT. LTD. (IN) | 2024-02-27 | — | — | US | disclosed |
| US-20230093176-A1 | PROCESS FOR STEREOSPECIFIC SYNTHESIS OF VITAMIN K2 AND ITS NOVEL INTERMEDIATES | SYNERGIA LIFE SCIENCES PVT. LTD. (IN) | 2023-03-23 | — | — | US | disclosed |
| WO-2023031841-A1 | A PROCESS FOR THE STEREOSPECIFIC SYNTHESIS OF VITAMIN K2 AND ITS INTERMEDIATES | SYNERGIA LIFE SCIENCES PVT. LTD. (IN) | 2023-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912654-B2 | Process for stereospecific synthesis of vitamin K2 and its novel intermediates | PROC, VKORC1, NADK | TRPV1 2783/4885FNTA 1028/4885FNTB 1330/4885 |
| US-20230093176-A1 | PROCESS FOR STEREOSPECIFIC SYNTHESIS OF VITAMIN K2 AND ITS NOVEL INTERMEDIATES | PROC, VKORC1, NADK | TRPV1 2783/4885FNTA 1028/4885FNTB 1330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.